What is the current Liquid Embolic Agent market size?

The current Liquid Embolic Agent market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Liquid Embolic Agent market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing demand.

What are the key drivers of the Liquid Embolic Agent market?

Key drivers include rising prevalence of cardiovascular diseases and advancements in medical technology.

What are the major challenges facing the Liquid Embolic Agent market?

Challenges include high costs, limited reimbursement, and stringent regulatory requirements.

Which regions are leading the Liquid Embolic Agent market?

North America and Europe are currently leading the market, due to strong healthcare infrastructure.

Who are the top companies in the Liquid Embolic Agent market?

Top companies include Medtronic, Boston Scientific, and Terumo, offering a range of embolic agents.

What future opportunities exist in the Liquid Embolic Agent market?

Future opportunities include emerging markets, innovative products, and growing demand for minimally invasive procedures.

How is technology impacting the Liquid Embolic Agent market?

Advances in technology are improving product efficacy, safety, and ease of use, driving market growth.

What is the current regulatory landscape for the Liquid Embolic Agent market?

The regulatory landscape is complex, with strict guidelines and approvals required for new products and indications.

What is the future outlook for the Liquid Embolic Agent market?

The future outlook is positive, with increasing demand and advancements in technology driving market expansion.

Liquid Embolic Agent Growth Trends & Strategic Outlook 2033

Liquid Embolic Agent by Application (Arteriovenous Malformations, Hypervascular Tumors, Other), by Types (6% EVOH, 8% EVOH), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 96

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Liquid Embolic Agent Market Overview

The Liquid Embolic Agent market refers to the industry involved in the development and distribution of liquid embolic agents used to treat various medical conditions. As a crucial segment of the healthcare industry, the Liquid Embolic Agent market size is estimated to be around $1.3 billion. The growth outlook for the Liquid Embolic Agent market forecast is positive, driven by an increasing demand for minimally invasive procedures and advancements in medical technology. The market forecast suggests a compound annual growth rate (CAGR) of 8.5% from 2026 to 2033, driven by macro drivers such as an aging population and an increasing prevalence of chronic diseases. The industry expansion is expected to be shaped by key forces such as technology shifts, regulatory approvals, and competitive intensity.

Loading chart…

The largest region in the Liquid Embolic Agent market is North America, accounting for over 40% of the global market share, while the fastest-growing region is Asia Pacific, driven by an increasing demand for minimally invasive procedures and a growing healthcare infrastructure. Key forces shaping the industry include technology shifts, such as the development of new liquid embolic agents, regulatory approvals, and competitive intensity, with major players investing heavily in research and development to stay ahead in the market. The current market trends and outlook suggest a promising future for the Liquid Embolic Agent market, with opportunities for growth and expansion in various regions and segments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Balt; MicroVention; CERENOVUS; Meril Life; Saikesaisi Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Liquid Embolic Agent market is poised for significant growth, driven by various factors that are expected to influence its size and growth forecast. The following sections outline the key dynamics shaping the market:

Growth Drivers2 items

Advances in minimally invasive procedures are driving the adoption of Liquid Embolic Agents, leading to an increase in the Liquid Embolic Agent market size

Rising demand for effective treatments of vascular malformations and aneurysms is fueling the growth forecast of the Liquid Embolic Agent market

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players in the Liquid Embolic Agent market, thus affecting its growth forecast

Potential complications associated with the use of Liquid Embolic Agents, such as ischemia and necrosis, are hindering the market growth

Opportunities2 items

Increasing investment in research and development is expected to lead to the introduction of new and innovative Liquid Embolic Agents, driving the Liquid Embolic Agent market size

Growing demand for non-surgical treatments in emerging economies is creating opportunities for players in the Liquid Embolic Agent market to expand their presence

Challenges2 items

Intense competition among existing players in the Liquid Embolic Agent market is making it challenging for new entrants to gain market share

Fluctuations in raw material prices and supply chain disruptions are affecting the production costs and availability of Liquid Embolic Agents, thus impacting the growth forecast

Market Segmentation

Loading chart…

The Liquid Embolic Agent segmentation by application is a crucial aspect of the market, as it enables a deeper understanding of the diverse uses of these agents. The primary applications of liquid embolic agents include tumor embolization, arteriovenous malformation (AVM) embolization, and aneurysm embolization. Each of these applications contributes significantly to the overall Liquid Embolic Agent market size, with varying degrees of market share. For instance, tumor embolization holds a substantial share due to the increasing incidence of cancer and the growing demand for minimally invasive procedures.

The types of liquid embolic agents are another essential segment of the market, comprising cyanoacrylates, ethanol, and n-butyl cyanoacrylate (n-BCA). These subtypes have distinct characteristics and are used in different clinical settings. Cyanoacrylates, for example, are commonly used for AVM embolization due to their rapid polymerization properties, while ethanol is often utilized for tumor embolization due to its ability to induce tumor necrosis. Understanding the market taxonomy of these subtypes is vital for assessing the overall market size and growth prospects of the Liquid Embolic Agent market.

Liquid Embolic Agent Segmentation Breakdown7 items

Application

Arteriovenous Malformations

Hypervascular Tumors

Other

Types

6% EVOH

8% EVOH

Regional Insights

Loading chart…

The Liquid Embolic Agent market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of minimally invasive procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and significant infrastructure investments. In Europe, drivers include a strong regulatory framework, increasing adoption of liquid embolic agents, and a growing geriatric population. Asia Pacific's growth is driven by rising healthcare expenditure, increasing awareness of minimally invasive procedures, and a large patient pool. Latin America's growth is driven by government initiatives to improve healthcare infrastructure, while the Middle East & Africa region is driven by rising demand for specialized healthcare services and increasing foreign investments.

The regional forecast suggests that Asia Pacific will experience the highest growth rate, driven by emerging economies and increasing demand for liquid embolic agents. North America and Europe are expected to maintain their market share, while Latin America and the Middle East & Africa are expected to experience moderate growth. Understanding these regional trends is crucial for stakeholders to navigate the Liquid Embolic Agent market and capitalize on emerging opportunities.

Competitive Landscape

The Liquid Embolic Agent market exhibits a moderately consolidated structure, driven by a mix of global players and local/regional companies. The Liquid Embolic Agent competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and strategic partnerships to maintain their market position, while local companies rely on regional distribution networks and competitive pricing.

Companies in the Liquid Embolic Agent market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and supply chain risks. To mitigate these risks, companies focus on technology, service model, channel strength, customization, and cost advantages to differentiate themselves. The following companies illustrate this trend:

Medtronic: regional expansion

Terumo: premium pricing

Balt: innovation pipeline

MicroVention: local manufacturing

CERENOVUS: OEM tie-ups

Meril Life: vertical integration

Key Liquid Embolic Agent Companies7 items

Medtronic

Terumo

Balt

MicroVention

CERENOVUS

Meril Life

Saikesaisi Holding

Market Ecosystem

The Liquid Embolic Agent ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream end users. This ecosystem can be broadly segmented into three primary stages: upstream, where raw materials and components are sourced; midstream, where integrators and manufacturers produce the embolic agents; and downstream, where channels and end users interact. Value is created and captured through the development, manufacturing, and distribution of these agents, with each stage influencing the overall efficiency and effectiveness of the ecosystem.

Raw material suppliers — providing essential components

OEMs/manufacturers — producing Liquid Embolic Agents

Distributors/channel partners — facilitating agent delivery

End users/buyers — utilizing embolic agents in medical procedures

Regulators/standards bodies — establishing safety and efficacy standards

Service providers/after-sales — offering support and maintenance services

Data/analytics providers — supplying insights for ecosystem optimization

Within the Liquid Embolic Agent ecosystem, control points are primarily held by regulators and standards bodies, as they influence adoption through approvals and compliance requirements. Dependency risks arise from input constraints, such as the availability of raw materials, and standards, which can impact manufacturing and distribution. Switching costs and partnerships can also affect ecosystem dynamics, particularly in terms of interoperability requirements between different agents and medical devices. Furthermore, the ecosystem may differ by region due to varying regulatory frameworks and market demands, highlighting the need for a nuanced understanding of the Liquid Embolic Agent ecosystem through value chain analysis.

Recent Industry Insights

The Liquid Embolic Agent industry trends have witnessed significant developments over the last 12-18 months, driven by strategic partnerships, mergers, and acquisitions. Notably, key players have formed alliances to enhance their product portfolios and expand their market presence. Furthermore, there have been notable product launches, with a focus on improving efficacy and safety profiles. Regulatory bodies have also introduced changes, aiming to ensure stricter safety standards and more efficient approval processes. As a result, the Liquid Embolic Agent industry is experiencing a shift towards more innovative and patient-centric solutions, with companies investing heavily in research and development to stay ahead of the competition.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Liquid Embolic Agent market. The market attractiveness is moderate, driven by increasing demand for minimally invasive procedures and advancements in liquid embolic technology. The competitive intensity is high, with key players investing in research and development to improve product efficacy and safety. The long-term outlook for the Liquid Embolic Agent market outlook is positive, with opportunities for growth in emerging markets and innovation in new product development.

The innovation landscape is evolving, with a focus on developing more effective and safer liquid embolic agents. The demand–supply balance is currently stable, but may be impacted by key risk factors such as regulatory changes and supply chain disruptions. Overall, the Liquid Embolic Agent market is expected to experience steady growth, driven by increasing adoption and advancements in technology.

12 items

1. Executive Summary

2. Liquid Embolic Agent Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Liquid Embolic Agent Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Liquid Embolic Agent Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Liquid Embolic Agent Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Liquid Embolic Agent Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Liquid Embolic Agent Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Liquid Embolic Agent Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Liquid Embolic Agent Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Liquid Embolic Agent Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Liquid Embolic Agent Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Liquid Embolic Agent Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Liquid Embolic Agent Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Liquid Embolic Agent Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Liquid Embolic Agent Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Liquid Embolic Agent Market Competition by Key Manufacturers

9.1. Global Liquid Embolic Agent Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Liquid Embolic Agent: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Terumo

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Balt

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. MicroVention

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. CERENOVUS

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Meril Life

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Saikesaisi Holding

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Liquid Embolic Agent Market

Figure 4: Global Liquid Embolic Agent Market: Drivers

Figure 5: Global Liquid Embolic Agent Market: Challenges

Figure 6: Global Liquid Embolic Agent Market: Trends

Figure 7: Global Liquid Embolic Agent Market: Opportunity

Figure 8: Global Liquid Embolic Agent Market: Restraint

Figure 9: Global Liquid Embolic Agent Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Liquid Embolic Agent Market Value (USD Million) By Region

Figure 19: Global Liquid Embolic Agent Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Liquid Embolic Agent Market Value (USD Million) By Region

Figure 27: Global Liquid Embolic Agent Market Share (%) By: Regions (2032)

Figure 28: Global Liquid Embolic Agent Market Volume (K) By Region

Figure 29: Global Liquid Embolic Agent Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Liquid Embolic Agent Market Value (USD Million) By Region

Figure 37: Global Liquid Embolic Agent Market Share (%) By: Regions (2032)

Figure 38: Global Liquid Embolic Agent Market Volume (K) By Region

Figure 39: Global Liquid Embolic Agent Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

109 items

Table 1: Market Segmentation Analysis

Table 2: Global Liquid Embolic Agent Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Liquid Embolic Agent Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Liquid Embolic Agent Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Liquid Embolic Agent Market Value (USD Million) By Region

Table 14: Global Liquid Embolic Agent Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Liquid Embolic Agent Market Volume (K) By Region

Table 31: Global Liquid Embolic Agent Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Liquid Embolic Agent Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Liquid Embolic Agent Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Liquid Embolic Agent Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Terumo Basic Information And Sales Area

Table 54: Terumo. Products Portfolio

Table 55: Balt Basic Information And Sales Area

Table 56: Balt. Products Portfolio

Table 57: MicroVention Basic Information And Sales Area

Table 58: MicroVention. Products Portfolio

Table 59: CERENOVUS Basic Information And Sales Area

Table 60: CERENOVUS. Products Portfolio

Table 61: Meril Life Basic Information And Sales Area

Table 62: Meril Life. Products Portfolio

Table 63: Saikesaisi Holding Basic Information And Sales Area

Table 64: Saikesaisi Holding. Products Portfolio

Table 65: Global Market Value (USD Million) (2025-2032) By Application

Table 66: Global Market Share (%) By Application (2032)

Table 67: Global Market Value (USD Million) (2025-2032) By Types

Table 68: Global Market Share (%) By Types (2032)

Table 69: Global Market Volume (K) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Volume (K) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Liquid Embolic Agent Market Value (USD Million) By Region

Table 74: Global Liquid Embolic Agent Market Share (%) By Region (2025-2032)

Table 75: North America Market Value (USD Million) (2025-2032) By Country

Table 76: North America Market Value (USD Million) (2025-2032) By Application

Table 77: North America Market Value (USD Million) (2025-2032) By Types

Table 78: Europe Market Value (USD Million) (2025-2032) By Country

Table 79: Europe Market Value (USD Million) (2025-2032) By Application

Table 80: Europe Market Value (USD Million) (2025-2032) By Types

Table 81: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 82: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 83: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 84: South America Market Value (USD Million) (2025-2032) By Country

Table 85: South America Market Value (USD Million) (2025-2032) By Application

Table 86: South America Market Value (USD Million) (2025-2032) By Types

Table 87: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 88: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 89: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 90: Global Liquid Embolic Agent Market Volume (K) By Region

Table 91: Global Liquid Embolic Agent Market Share (%) By Region (2025-2032)

Table 92: North America Market Volume (K) (2025-2032) By Country

Table 93: North America Market Volume (K) (2025-2032) By Application

Table 94: North America Market Volume (K) (2025-2032) By Types

Table 95: Europe Market Volume (K) (2025-2032) By Country

Table 96: Europe Market Volume (K) (2025-2032) By Application

Table 97: Europe Market Volume (K) (2025-2032) By Types

Table 98: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 99: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 100: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 101: South America Market Volume (K) (2025-2032) By Country

Table 102: South America Market Volume (K) (2025-2032) By Application

Table 103: South America Market Volume (K) (2025-2032) By Types

Table 104: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 105: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 106: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 107: Research Programs/Design For This Report

Table 108: Key Data Information From Secondary Sources

Table 109: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Liquid Embolic Agent Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Terumo; Balt; MicroVention; CERENOVUS; Meril Life; Saikesaisi Holding
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in minimally invasive procedures are driving the adoption of Liquid Embolic Agents, leading to an increase in the Liquid Embolic Agent market size

Rising demand for effective treatments of vascular malformations and aneurysms is fueling the growth forecast of the Liquid Embolic Agent market

Restraints2 items

Stringent regulatory requirements and high development costs are limiting the entry of new players in the Liquid Embolic Agent market, thus affecting its growth forecast

Potential complications associated with the use of Liquid Embolic Agents, such as ischemia and necrosis, are hindering the market growth

Opportunities2 items

Increasing investment in research and development is expected to lead to the introduction of new and innovative Liquid Embolic Agents, driving the Liquid Embolic Agent market size

Growing demand for non-surgical treatments in emerging economies is creating opportunities for players in the Liquid Embolic Agent market to expand their presence

Challenges2 items

Intense competition among existing players in the Liquid Embolic Agent market is making it challenging for new entrants to gain market share

Fluctuations in raw material prices and supply chain disruptions are affecting the production costs and availability of Liquid Embolic Agents, thus impacting the growth forecast

Market Segmentation

Loading chart…

Liquid Embolic Agent Segmentation Breakdown7 items

Application

Arteriovenous Malformations

Hypervascular Tumors

Other

Types

6% EVOH

8% EVOH

Regional Insights

Loading chart…

Competitive Landscape

Medtronic: regional expansion

Terumo: premium pricing

Balt: innovation pipeline

MicroVention: local manufacturing

CERENOVUS: OEM tie-ups

Meril Life: vertical integration

Key Liquid Embolic Agent Companies7 items

Medtronic

Terumo

Balt

MicroVention

CERENOVUS

Meril Life

Saikesaisi Holding

Market Ecosystem

Raw material suppliers — providing essential components

OEMs/manufacturers — producing Liquid Embolic Agents

Distributors/channel partners — facilitating agent delivery

End users/buyers — utilizing embolic agents in medical procedures

Regulators/standards bodies — establishing safety and efficacy standards

Service providers/after-sales — offering support and maintenance services

Data/analytics providers — supplying insights for ecosystem optimization

Recent Industry Insights

Analyst Overview

Table of Contents